BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32954014)

  • 1. Changes in nano-mechanical properties of human epidermal cornified cells in children with atopic dermatitis.
    Haftek M; McAleer MA; Jakasa I; McLean WI; Kezic S; Irvine AD
    Wellcome Open Res; 2020; 5():97. PubMed ID: 32954014
    [No Abstract]   [Full Text] [Related]  

  • 2. Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis.
    Riethmuller C; McAleer MA; Koppes SA; Abdayem R; Franz J; Haftek M; Campbell LE; MacCallum SF; McLean WHI; Irvine AD; Kezic S
    J Allergy Clin Immunol; 2015 Dec; 136(6):1573-1580.e2. PubMed ID: 26071937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filaggrin loss-of-function mutations and levels of filaggrin degradation products in adult patients with atopic dermatitis in Croatia.
    Jurakic Toncic R; Kezic S; Jakasa I; Ljubojevic Hadzavdic S; Balic A; Petkovic M; Pavicic B; Zuzul K; Marinovic B
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1789-1794. PubMed ID: 31989686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of filaggrin monomers, its metabolites and corneocyte surface texture in individuals with a history of atopic dermatitis and controls.
    Engebretsen KA; Bandier J; Kezic S; Riethmüller C; Heegaard NHH; Carlsen BC; Linneberg A; Johansen JD; Thyssen JP
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):796-804. PubMed ID: 29360238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency.
    Kezic S; O'Regan GM; Lutter R; Jakasa I; Koster ES; Saunders S; Caspers P; Kemperman PM; Puppels GJ; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Fallon PG; McLean WH; Irvine AD
    J Allergy Clin Immunol; 2012 Apr; 129(4):1031-9.e1. PubMed ID: 22322004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filaggrin Expression and Processing Deficiencies Impair Corneocyte Surface Texture and Stiffness in Mice.
    Thyssen JP; Jakasa I; Riethmüller C; Schön MP; Braun A; Haftek M; Fallon PG; Wróblewski J; Jakubowski H; Eckhart L; Declercq W; Koppes S; Engebretsen KA; Bonefeld C; Irvine AD; Keita-Alassane S; Simon M; Kawasaki H; Kubo A; Amagai M; Matsui T; Kezic S
    J Invest Dermatol; 2020 Mar; 140(3):615-623.e5. PubMed ID: 31479664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity.
    Kezic S; O'Regan GM; Yau N; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Rowland M; McLean WH; Irvine AD
    Allergy; 2011 Jul; 66(7):934-40. PubMed ID: 21261659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of filaggrin mutations on Raman spectra and biophysical properties of the stratum corneum in mild to moderate atopic dermatitis.
    Mlitz V; Latreille J; Gardinier S; Jdid R; Drouault Y; Hufnagl P; Eckhart L; Guinot C; Tschachler E
    J Eur Acad Dermatol Venereol; 2012 Aug; 26(8):983-90. PubMed ID: 21812836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis.
    Jung M; Choi J; Lee SA; Kim H; Hwang J; Choi EH
    J Dermatol Sci; 2014 Dec; 76(3):231-9. PubMed ID: 25315296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion of Staphylococcus aureus to Corneocytes from Atopic Dermatitis Patients Is Controlled by Natural Moisturizing Factor Levels.
    Feuillie C; Vitry P; McAleer MA; Kezic S; Irvine AD; Geoghegan JA; Dufrêne YF
    mBio; 2018 Aug; 9(4):. PubMed ID: 30108169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratum corneum markers of innate and T helper cell-related immunity and their relation to the disease severity in Croatian patients with atopic dermatitis.
    Jurakic Toncic R; Jakasa I; Sun Y; Hurault G; Ljubojevic Hadzavdic S; Tanaka RJ; Pavicic B; Balic A; Zuzul K; Petkovic M; Kezic S; Marinovic B
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):1186-1196. PubMed ID: 33480075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema.
    Jungersted JM; Scheer H; Mempel M; Baurecht H; Cifuentes L; Høgh JK; Hellgren LI; Jemec GB; Agner T; Weidinger S
    Allergy; 2010 Jul; 65(7):911-8. PubMed ID: 20132155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice.
    Kawasaki H; Nagao K; Kubo A; Hata T; Shimizu A; Mizuno H; Yamada T; Amagai M
    J Allergy Clin Immunol; 2012 Jun; 129(6):1538-46.e6. PubMed ID: 22409988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filaggrin and Skin Barrier Function.
    Kezic S; Jakasa I
    Curr Probl Dermatol; 2016; 49():1-7. PubMed ID: 26844893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes.
    O'Regan GM; Kemperman PM; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Rowland M; Puppels GJ; McLean WH; Caspers PJ; Irvine AD
    J Allergy Clin Immunol; 2010 Sep; 126(3):574-80.e1. PubMed ID: 20621340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year.
    Kelleher M; Dunn-Galvin A; Hourihane JO; Murray D; Campbell LE; McLean WHI; Irvine AD
    J Allergy Clin Immunol; 2015 Apr; 135(4):930-935.e1. PubMed ID: 25618747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-life regional and temporal variation in filaggrin-derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitis.
    McAleer MA; Jakasa I; Raj N; O'Donnell CPF; Lane ME; Rawlings AV; Voegeli R; McLean WHI; Kezic S; Irvine AD
    Br J Dermatol; 2018 Aug; 179(2):431-441. PubMed ID: 29691836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filaggrin-gene mutation has minimal effect on the disease severity in the lesions of atopic dermatitis.
    Ota M; Sasaki T; Ebihara T; Yokosawa E; Murakami Y; Matsunaka H; Chinuki Y; Amagai M; Morita E
    J Dermatol; 2021 Nov; 48(11):1688-1699. PubMed ID: 34322929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical severity correlates with impaired barrier in filaggrin-related eczema.
    Nemoto-Hasebe I; Akiyama M; Nomura T; Sandilands A; McLean WH; Shimizu H
    J Invest Dermatol; 2009 Mar; 129(3):682-9. PubMed ID: 18818676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu.
    Kezic S; McAleer MA; Jakasa I; Goorden SMI; der Vlugt KG; Beers-Stet FS; Meijer J; Roelofsen J; Nieman MM; van Kuilenburg ABP; Irvine AD
    Br J Dermatol; 2022 Jun; 186(6):988-996. PubMed ID: 34993951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.